PPT-Data Source: Special analyses, Medicare 5 percent sample. Patients aged 66 and older,

valvular heart disease Figure 41 Cardiovascular disease in patients with or without CKD 2013 Vol 1 CKD Ch 4 2 Table 41 Prevalence of cardiovascular comorbidities amp procedures . Volume 1: Chronic Kidney Disease. Chapter 2: Identification and Care of Patients With CKD. 2. Table A. ICD-9-CM and ICD-10-CM codes for Chronic Kidney Disease (CKD) . stages (introduced . in 2006). Table A. ICD-9-CM and ICD-10-CM codes for Chronic Kidney Disease (CKD) stages. Volume 1: Chronic Kidney Disease. 2018 Annual Data Report . Volume . 1 CKD, . Chapter 3. Chapter 3:. Morbidity and Mortality. 2. vol. 1 Table 3.1 Unadjusted and adjusted all-cause mortality rates per 1,000 patient-years at risk for Medicare patients aged 66 and older, by CKD status, 2016. valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . dialysis; . Tx. , transplant. . v. ol. . 2 Figure . 7.1. Incident & December 31 point prevalent ESRD patients (. aged 0-19 years). (a) Incidence . of ESRD in . children. Vol. 2, ESRD, . Ch. 7. 2016 Annual Data Report, Vol . 1, CKD, . Ch. . 3. 2. Data source: Medicare 5 percent sample. January 1, 2014 point prevalent patients aged 66 and older. . Adj. : age/sex/race. Ref: all patients, 2014. Abbreviation: CKD, chronic kidney disease.. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2007–2012 participants aged 20 & older. Whisker lines indicate 95% confidence intervals. Abbreviations: CKD, chronic kidney disease. This graphic also appears as Figure 1.2. Vol. 1, CKD, . Ch. . 6. 2. Data source: Medicare 5 percent sample. Abbreviations: CKD, chronic kidney disease; CHF, congestive heart failure, DM, diabetes mellitus.. v. ol 1 Table . 6.1 Point prevalent distribution of Medicare fee-for-service patients aged 65+ and total annual costs of Medicare Parts A and B services, by DM, CHF, and/or CKD, 2012. Tx. , transplant.. Figure . 8.1 . Number of (a) incident and (b) December 31 point prevalent ESRD . pediatric . patients (aged 0–21 years), by modality, 1996-2013. Vol 2, ESRD, . Ch. 8. 2. Incident. Vol. 1, CKD, . Ch. 2. 2. Table A. ICD-9-CM Codes. 585.1. Chronic kidney disease, Stage 1. 585.2. Chronic kidney disease, Stage 2 (mild). 585.3. Chronic kidney disease, Stage 3 (moderate). 585.4. Chronic kidney disease, Stage 4 (severe). Adj. : age/sex/race/prior year hospitalization/comorbidities. Ref: 2012 patients. Abbreviations: CKD, chronic kidney disease.. vol 1 Figure 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years at risk) for Medicare patients aged 66 and older, by CKD status and year, . Adj. : age/sex/race. Ref: all patients, 2013. Abbreviation: CKD, chronic kidney disease.. Table 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years . at . risk) for Medicare patients aged 66 and older, by CKD status, 2013. Figure . 7.1 . Sources of prescription drug coverage in Medicare enrollees, by population, 2014. 2016 Annual Data Report, Vol 1, CKD, Ch . 7. 2. a The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php. . valvular. heart disease; VTE/PE, venous thromboembolism and pulmonary embolism.. Figure . 4.1 Prevalence . of cardiovascular diseases in patients with or without CKD, 2014 . . 2016 Annual Data Report, Vol 1, CKD, . Af. Am, African American; AKI, acute kidney injury; CKD, chronic kidney disease.. vol. 2 Table 2.1 HP2020 CKD-3 Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post-discharge: Target 12.3%.